Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now In 2014, a breakthrough at Google ...
High manufacturing costs are limiting patient access to CAR T cell therapies, according to new research, which indicates that decentralization, vector-free modification technologies, and AI would help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback